Newfound Research Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity Low Volatility Factor ETF
FDLO
|
+$1.17M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$1.16M |
| 3 |
Fidelity Quality Factor ETF
FQAL
|
+$1.16M |
| 4 |
JPMorgan US Quality Factor ETF
JQUA
|
+$1.16M |
| 5 |
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
|
+$1.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan US Momentum Factor ETF
JMOM
|
+$929K |
| 2 |
Fidelity Momentum Factor ETF
FDMO
|
+$926K |
| 3 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$866K |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$146K |
| 5 |
Take-Two Interactive
TTWO
|
+$145K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.38% |
| 2 | Healthcare | 4.32% |
| 3 | Technology | 3.87% |
| 4 | Industrials | 2.65% |
| 5 | Consumer Staples | 2.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Roper Technologies
ROP
$41.8B
| – | – |
-275
| Closed | -$119K |
|
152
Revvity
RVTY
$14.5B
| – | – |
-783
| Closed | -$112K |
|
153
Bio-Techne
TECH
$11.4B
| – | – |
-516
| Closed | -$41K |
|
154
Tractor Supply
TSCO
$18.1B
| – | – |
-1,980
| Closed | -$56K |
|
|
155
Take-Two Interactive
TTWO
$43.6B
| – | – |
-700
| Closed | -$145K |
|
156
Workday
WDAY
$47.8B
| – | – |
-458
| Closed | -$110K |
|
|
XLNX
157
DELISTED
Xilinx Inc
XLNX
| – | – |
-1,033
| Closed | -$146K |
|
|
ALXN
158
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-680
| Closed | -$106K |
|
|
TIF
159
DELISTED
Tiffany & Co.
TIF
| – | – |
-466
| Closed | -$61K |
|
Similar funds
Newfound Research's Q1 2021 Portfolio in Review
As of Q1 2021, Newfound Research held 159 positions worth $43.2M, up 11% from $38.9M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Newfound Research deployed $2.88M of net new capital in Q1 2021, opening 33 new positions and adding to 13 existing holdings. Its largest new stake was Fidelity Low Volatility Factor ETF: 27,216 shares worth $1.19M.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 69% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was JPMorgan US Momentum Factor ETF, an estimated $929K trimmed.
- Newfound Research's largest Q1 2021 buy was Fidelity Low Volatility Factor ETF: 27,216 shares worth $1.19M.
- Newfound Research added most to Vanguard US Momentum Factor ETF in Q1 2021, an estimated $984K increase.
- Newfound Research's biggest Q1 2021 reduction was JPMorgan US Momentum Factor ETF, cutting an estimated $929K.
- Newfound Research fully exited Xilinx Inc in Q1 2021, selling an estimated $146K.
- Newfound Research's ten largest holdings make up 72% of its $43.2M portfolio in Q1 2021.
- Newfound Research opened 33 new positions and closed 32 in Q1 2021.
- Newfound Research's portfolio value rose 11% quarter-over-quarter to $43.2M.
Based on Newfound Research's 13F filing for Q1 2021, filed 28 Apr 2021.